David James Lennon
CIK 1995275 · CHIEF EXECUTIVE OFFICER · last filed 2026-09-18
David James Lennon is a CHIEF EXECUTIVE OFFICER who has filed 16 SEC Form 4 insider transactions across 2 companies since 2023. The most recent filing, for WHWK, was dated Sep 18, 2026. Across all open-market trades the lifetime net is −$1.1M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $1.8M across reported positions. 4 Form 144 notices of planned sales are also on file; the latest, for WHWK on Apr 9, 2026, lists the filer as an officer and director.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
WHWK price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
17383 SUNSET BLVD, SUITE A250
PACIFIC PALISADES, CA 90272
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| WHWK | CHIEF EXECUTIVE OFFICER | 569,643 | $3.13 | $1.78M | -$1.06M | 8 | 2026-09-18 |
| Whitehawk Therapeutics, Inc. (AADI) Delisted | CHIEF EXECUTIVE OFFICER | 33,429 | $2.05 | $68.5K | -$32.2K | 4 | 2025-03-03 |
Recent Filings
16 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-09-18 | WHWK | Grant (A) | — | $0 | EDGAR |
| 2026-09-15 | WHWK | Grant (A) | — | $0 | EDGAR |
| 2026-05-18 | WHWK | Grant (A) | +51,021 | $200.0K | EDGAR |
| 2026-04-10 | WHWK | Sell (S) | −14,500 | -$49.0K | EDGAR |
| 2026-04-09 | WHWK | Notice (144) Officer, Director · Planned Apr 9, 2026 Sold: Form 4 filed Apr 10, 2026 |
−4,364 | -$14.8K | EDGAR |
| 2026-04-08 | WHWK | Sell (S) | −260,427 | -$899.5K | EDGAR |
| 2026-04-03 | WHWK | Mixed | +748,970 | -$93.5K | EDGAR |
| 2026-04-02 | WHWK | Notice (144) Officer, Director · Planned Apr 2, 2026 Sold: Form 4 filed Apr 3, 2026 |
−297,421 | -$1.03M | EDGAR |
| 2026-03-10 | WHWK | Mixed | +11,150 | -$16.9K | EDGAR |
| 2025-04-03 | WHWK | Grant (A) | — | $0 | EDGAR |
10b5-1: the filer ticked the box for trades made under a Rule 10b5-1 trading plan, which sets the sales (or buys) in advance, so they say less about the insider's view at the time than a discretionary trade. The plan's adoption date is shown when the filing's footnotes give it.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment, and an amended or cancelled notice is not listed. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes. Someone who is no longer an officer or director (or never was) files no Form 4, so for them a sale shows up only on a later notice, which lists the seller's sales from the 3 months before it. "No sale on file" means neither record shows one; a dash in Net $ means the value filed on the notice doesn't fit the stock's price (likely a typo).